Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

The Challenge Of HSCs Procurement For Gene Therapy: Exploring Plerixafor As Mobilization Agent

Maria Rosa Lidonnici, PhD, Annamaria Aprile, MSc, Marta Claudia Frittoli, MD, Giacomo Mandelli, PhD, Bernhard Gentner, MD, Laura Bellio, MD, Elena Cassinerio, MD, Laura Zanaboni, MD, Maria Domenica Cappellini, MD, Silvano Rossini, MD, Fabio Ciceri, MD, Sarah Marktel, MD, Giuliana Ferrari, PhD

Blood (2013) 122 (21): 2901.

https://doi.org/10.1182/blood.V122.21.2901.2901

Published: 2013

Journal Articles

Plerixafor Single Agent for Autologous Stem Cells Mobilization and Collection in Adult Thalassemic Patients: Towards the Assessment of the Suitable Hematopoietic Stem Cell Source for Gene Therapy of Beta-Thalassemia.

Marta Claudia Frittoli, MD, Bernhard Gentner, MD $, Maria Rosa Lidonnici, PhD, Annamaria Aprile, Laura Bellio, MD, Salvatore Gattillo, MD, Matilde Zambelli, Raffaella Milani, Elena Cassinerio, MD, Laura Zanaboni, MD, Silvano Rossini, MD, Maria Domenica Cappellini, MD, Fabio Ciceri, MD, Giuliana Ferrari, PhD, Sarah Marktel, MD

Blood (2012) 120 (21): 586.

https://doi.org/10.1182/blood.V120.21.586.586

Published: 2012

Journal Articles

Epitope-Specific Typing (EST) for HLA-DPB1 Matching: Proof of Principle for an Innovative Approach to Unrelated Hematopoietic Stem Cell Donor Selection.

Elisabetta Zino, BS, Luca Vago, MD, Simona Di Terlizzi, BS, Benedetta Mazzi, BS, Luigi D’ Amato, BS, Silvano Rossini, MD, Fabio Ciceri, MD, Maria G. Roncarolo, MD, Claudio Bordignon, MD, Katharina Fleischhauer, MD

Blood (2006) 108 (11): 3130.

https://doi.org/10.1182/blood.V108.11.3130.3130

Published: 2006

Journal Articles

Impaired GvL Potential of Natural Killer Cells Early Reconstituting Following Haploidentical HSCT.

Luca Vago, MD, Elisabetta Zino, BS, Simona Di Terlizzi, BS, Barbara Forno, MS, Maria T. Lupo Stanghellini, MD, Serena K. Perna, MD, Benedetta Mazzi, BS, Jacopo Peccatori, MD, Silvano Rossini, MD, Maria G. Roncarolo, MD, Chiara Bonini, MD, Fabio Ciceri, MD, Claudio Bordignon, MD, Katharina Fleischhauer, MD

Blood (2006) 108 (11): 3223.

https://doi.org/10.1182/blood.V108.11.3223.3223

Published: 2006

Journal Articles

Receptor Repertoire Reconstitution Suggests Acquisition of Patient-Specific Tolerance by Natural Killer Cells Arising from Hematopoietic Progenitor Stem Cells after Haploidentical Transplantation.

Luca Vago, MD, Simona Di Terlizzi, BS, Elisabetta Zino, BS, Chiara F. Magnani, BS, Maria T. Lupo Stanghellini, MD, Zulma Magnani, PhD, Benedetta Mazzi, BS, Daniela Clerici, MD, Attilio Bondanza, MD, Marco Bregni, MD, Silvano Rossini, MD, Jacopo Peccatori, MD, Chiara Bonini, MD, Fabio Ciceri, MD, Claudio Bordignon, MD, Katharina Fleischhauer, MD

Blood (2005) 106 (11): 2905.

https://doi.org/10.1182/blood.V106.11.2905.2905

Published: 2005

NARROW

The Challenge Of HSCs Procurement For Gene Therapy: Exploring Plerixafor As Mobilization Agent

Plerixafor Single Agent for Autologous Stem Cells Mobilization and Collection in Adult Thalassemic Patients: Towards the Assessment of the Suitable Hematopoietic Stem Cell Source for Gene Therapy of Beta-Thalassemia.

Epitope-Specific Typing (EST) for HLA-DPB1 Matching: Proof of Principle for an Innovative Approach to Unrelated Hematopoietic Stem Cell Donor Selection.

Impaired GvL Potential of Natural Killer Cells Early Reconstituting Following Haploidentical HSCT.

Receptor Repertoire Reconstitution Suggests Acquisition of Patient-Specific Tolerance by Natural Killer Cells Arising from Hematopoietic Progenitor Stem Cells after Haploidentical Transplantation.

Email alerts

ASH Publications

American Society of Hematology

The Challenge Of HSCs Procurement For Gene Therapy: Exploring Plerixafor As Mobilization Agent

Plerixafor Single Agent for Autologous Stem Cells Mobilization and Collection in Adult Thalassemic Patients: Towards the Assessment of the Suitable Hematopoietic Stem Cell Source for Gene Therapy of Beta-Thalassemia.

Epitope-Specific Typing (EST) for HLA-DPB1 Matching: Proof of Principle for an Innovative Approach to Unrelated Hematopoietic Stem Cell Donor Selection.

Impaired GvL Potential of Natural Killer Cells Early Reconstituting Following Haploidentical HSCT.

Receptor Repertoire Reconstitution Suggests Acquisition of Patient-Specific Tolerance by Natural Killer Cells Arising from Hematopoietic Progenitor Stem Cells after Haploidentical Transplantation.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only